Clinical Trial Update: Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN） [Phase 3]

View source ↗

Summary

Phase 3 trial update for TQB2450 in recurrent or metastatic squamous cell cancer of the head and neck is in progress, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: UNKNOWN